The Transcription Factor Rfx3 Regulates β-Cell Differentiation, Function, and Glucokinase Expression
Year: 2010
Type: article
Abstract: OBJECTIVE: Pancreatic islets of perinatal mice lacking the transcription factor Rfx3 exhibit a marked reduction in insulin-producing beta-cells. The objective of this work was to unravel the cellular and molecular mechanisms underlying this deficiency. RESEARCH DESIGN AND METHODS: Immunofluorescence studies and quantitative RT-PCR experiments were used to study the emergence of insulin-positive cells, the expression of transcription factors implicated in the differentiation of beta-cells from endocrine progenitors, and the expression of mature beta-cell markers during development in Rfx3(-/-) and pancreas-specific Rfx3-knockout mice. RNA interference experiments were performed to document the consequences of downregulating Rfx3 expression in Min6 beta-cells. Quantitative chromatin immunoprecipitation (ChIP), ChIP sequencing, and bandshift experiments were used to identify Rfx3 target genes. RESULTS: Reduced development of insulin-positive cells in Rfx3(-/-) mice was not due to deficiencies in endocrine progenitors or beta-lineage specification, but reflected the accumulation of insulin-positive beta-cell precursors and defective beta-cells exhibiting reduced insulin, Glut-2, and Gck expression. Similar incompletely differentiated beta-cells developed in pancreas-specific Rfx3-deficient embryos. Defective beta-cells lacking Glut-2 and Gck expression dominate in Rfx3-deficent adults, leading to glucose intolerance. Attenuated Glut-2 and glucokinase expression, and impaired glucose-stimulated insulin secretion, were also induced by RNA interference-mediated inhibition of Rfx3 expression in Min6 cells. Finally, Rfx3 was found to bind in Min6 cells and human islets to two well-known regulatory sequences, Pal-1 and Pal-2, in the neuroendocrine promoter of the glucokinase gene. CONCLUSIONS: Our results show that Rfx3 is required for the differentiation and function of mature beta-cells and regulates the beta-cell promoter of the glucokinase gene.
Source: Diabetes
DOI: 10.2337/db09-0986
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Funders: National Science Foundation, Multiple Sclerosis Society, European Foundation for the Study of Diabetes, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Schweizerische Multiple Sklerose Gesellschaft, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases
Awards: G1815757601, Control of endocrine pancreatic function: dissecting the connexindependent pathway, G3022786702, G4023966104, TRANSGENIC MODEL OF INDUCIBLE DIABETES, Non invasive in vivo imaging of pancreatic beta cells : developing and testing innovative ligands and MRI contrast agents, Cell Fate Determination in the Developing Murine Pancreas, G7943099457, G8394228809, G8832621192
OpenAlex ID: W2049892677
